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1. Introduction 
Heterotopic gastric mucosa (HGM) is abnormally placed gastric mucosa outside of the 
stomach and can be found almost anywhere within the gastrointestinal tract (von Rahden et 
al., 2004). HGM is most commonly found in the esophagus. The most widely known HGM 
in the gastrointestinal tract is in the Meckel’s diverticulum. However, HGM is also found in 
the other part of the gastrointestinal tract including the tongue (Melato & Ferlito, 1975; 
Ortiz, 1982; Surana, 1993), duodenum (Kibria et al., 2009; Mann, 2000), gallbladder (Hayama 
et al., 2010; Popkharitoy et al., 2008), jejunum (Boybeyi et al., 2008; Nowak & Deppisch, 
1998), ileum (Chan et al., 1999; Erez et al., 1991), rectum (Garmendia et al., 2007; Vieth et al., 
2005) and anus (Steele et al., 2004). Interestingly, HGM of the umbilicus, a part of remnant 
alimentary tract has also been report (Heo et al., 2010). 
HGM patch (HGMP) of the proximal esophagus, also referred to as cervical inlet patch (CIP) 
is typically found in the proximal esophagus. It can also be found in the other part of the 
esophagus (Borhan-Manesh & Franum, 1991; Katsanos et al., 2010). On endoscopy, 
HGMP/CIP is clearly distinct from the esophageal squamous mucosa. HGMP/CIP is 
widely considered to be congenital in nature. However, it has also been proposed to be an 
acquired condition (Avidan et al., 2001; Meining & Baubouj, 2010). In clinical practice, 
HGMP/CIP is an under-recognized condition. The incidence reported in the literature 
varies with lower estimates in the earlier endoscopic studies (von Rahden et al., 2004). Later 
studies reported higher incidence (Ohara, 2010). The highest incidence was reported in an 
autopsy study (von Rahden et al., 2004). Use of newer endoscopic modalities has been 
reported to increase the pick up rates of HGMP/CIP.  
HGMP/CIP is largely asymptomatic and is incidental findings during endoscopy 
evaluations for other gastrointestinal complaints. Commonly reported symptoms are those 
symptoms complex referred to as extra-esophageal manifestations of gastro-esophagael 
reflux disorders. Other common upper aero-digestive disorders have also been linked to 
HGMP/CIP. Despite the benign nature of HGMP/CIP, serious and important complications 
have been reported (von Rahden et al., 2004). Furthermore, associations with higher 
frequencies of laryngopharyngeal malignancies have also been reported (Basseri et al., 2009).  
A clinico-pathologic classification has been proposed which categorized HGMP/CIP into 
five distinct groups based on clinical, endoscopic and histological findings (von Rahden et 
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al., 2004). The management strategies of HGMP/CIP are not well defined and are dependent 
on the severity of symptoms. However, other newer treatment modalities have also been 
reported. 
This chapter discusses the pathogenesis, the endoscopic features, clinical symptoms and the 
management of HGMP/CIP, an entity that is still under-recognised and is frequently missed 
during upper gastrointestinal endoscopy examinations.  
2. Pathogenesis 
HGMP is widely considered to be congenital in nature, as result of incomplete esophageal 
squamous epithelization during the embryogenic development stage (von Rahden et al., 
2004). Reports of HGMP in the esophagus of young children and even babies support this 
theory (Boybeyi et al., 2008; Georges et al., 2011; Macha et al., 2005; Surana et al., 1993). 
However, it has also been proposed to be acquired in nature, similar to Barrett’s esophagus 
(Avidan et al., 2001; Lauwers et al., 2005). There are based on similarities in the mucin and 
staining characteristics with CK7 and CK20 (Bogomoletz et al., 1988; Lauwers et al., 2005) 
between Barrett’s esophagus and HGMP/CIP. Reports of higher incidence of Barrett’s 
esophagus in patients with HGMP/CIP also suggested a link. Some has even proposed that 
the origins of HGMP/CIP may be different, congenital in children and acquired in adult 
(Lauwers et al., 2005). A recently proposed hypothesis suggested that HGMP/CIP developed 
from rupture retention cyst of the proximal esophagus (Meining & Baubouj, 2010). 
2.1 Origin of heterotopic gastric mucosal patch of the proximal esophagus  
2.1.1 Congenital origin theory 
Embryogenesis of the esophagus  
The development of the esophagus starts at the beginning of embryogenesis (Lieberman-
Meffert et al., 2002). The upper aerodigestive tract (oro, naso and largyngopharynx), 
respiratory tract, esophagus and stomach and duodenum arise from the same embryogenic 
segment. The stages of development are correlated with the length of the embryo. At 3 mm 
crown-rump length, the esophagus is mainly lined with columnar mucosa and during 
development at 110 CR length (equivalent to 24 weeks gestation), the squamous lining begin 
to replace the columnar lining starting at the mid esophagus, migrating in both directions. 
The cervical region of the esophagus is the last area to get stratification and this account for 
the common findings of HGMP in the proximal esophagus. The embryogenic development 
of the esophagus is shown in Figure 1.  
2.1.2 Acquired origins theories 
Metaplastic transformation of squamous mucosa to columnar mucosa from chronic acid injury  
It has also been proposed that the HGMP/CIP is an acquired condition as result of chronic 
inflammation from exposure to acid as part of gastroesophageal reflux disorders (Avidan et 
al., 2001; Lauwers et al., 2005). It is postulated that chronic acid exposure results in 
inflammation that leads to reactivation or proliferation of remnant columnar mucosa. These 
remnants columnar mucosa are present as microscopic foci in the esophageal lining or are 
covered by squamous mucosa. With chronic irritations, these foci develop into larger patch 
resulting in the formation of island of columnar mucosa, HGMP (Figure 2).  
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Time line
Tubular         Solid Vacuolization      Columnar       Keratinizing              HGMP  
 
Fig. 1. Embryogenesis of the esophagus: solidification of the hollow tubular esophagus 
occur with rapid cellular proliferation followed by vacuoles formations (recanalization), 
columnarization (cilia phase shaded rippled pink) and the final stage of squamous cell 
mucosa formation (keratinizing followed by dekeratinizing phase-shaded gray). HGMP 
form when the final phase is incomplete 
 
         Early        Chronic      HGMP/CIP  
Gastroesophageal    Esophagitis   Established Barrett’s  
         Reflux   
Fig. 2. Proposed acquired pathway through chronic reflux injury: Chronic acid (+/- pepsin 
and bile injury) leads to reflux esophagitis and reflux may reach the proximal esophagus 
resulting in similar changes. Chronic esophagitis leads to adaptive changes resulting in 
metaplasia metaplasia of the distal esophagus. Chronic injury in the proximal esophagus 
lead to reactivation of buried columnar cells resulting in formation of HGMP 
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Formation from ruptured retention cyst of the proximal esophagus 
This proposed theory suggested that HGMP/CIP formed from ruptured proximal esophageal 
glandular retention cysts (Meining & Baubouj, 2010). The initial process starts with occlusion 
of esophageal glands in the proximal esophagus resulting in formation of retention cysts 
which is internally covered by columnar epithelium. With further enlargement of the cysts, 
they eventually rupture resulting in the formation of HGMP (Figure 3). 
 
Formation of retention cysts 
 
 
Retention cysts coalesce and enlarge Formation of HGMP/CIP 
 
Fig. 3. Proposed acquired pathway through rupture of esophageal glandular retention cysts 
in the proximal esophagus 
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2.1.3 Others 
Others have proposed that development of HGMP/CIP in adult and children may be 
different based on differences in the mucin protein (MUC) staining. It has been suggested that 
two pathogenetic pathways maybe involved: focal upper esophageal mucosal 
misdevelopment in pediatric population and patchy metaplastic replacement of squamous 
mucosa in adults with gastroesophageal reflux disease. (Lauwers et al., 2005) 
3. Histology 
HGMP/CIP consists of columnar mucosa found in the stomach (Figure 4). HGMP/CIP can 
contain glandular mucosa of different types similar to those found in the stomach. One 
study showed that the body or fundus mucosa type parietal cells is the most common 
accounting for 50 to 65% with the antral type and mixed transition type accounting for 20 to 
25% respectively (Borhan-Manesh & Franum, 1991). Presence of acid producing parietal 
mucosa have been associated with acid production (Galan et al., 1998; Hamilton et al., 1986; 
Korkut et al., 2010; Yüksel et al., 2008). Mucin is also secreted (Bajbouj et al., 2009; 
Bogomoletz et al., 1988). The cytokeratin staining pattern of HGMP/CIP is similar to those 
seen with Barrett’s esophagus with surface epithelium staining for CK7 and CK20 (Figure 5). 
The staining pattern of the esophagus and stomach is shown in Figure 6 (Latchford et al., 
2001). 
 
 
Fig. 4. High power view showing boundary between squamous esophageal mucosa and the 
glandular mucosa of the HGMP/CIP 
Apart from CK, only one study had assessed the MUC protein profiles (Lauwers et al., 
2005). This study showed that MUC5AC was strongly expressed on the surface and pits 
but not in the glands of HGMP/CIP and antral mucosa. In contrast, MUC5AC positivity 
was noted on the surface, pits and the glands of Barrett’s esophagus. MUC6 similarly 
decorated the glands of HGMP/CIP and Barrett’s esophagus. MUC2 was expressed rarely 
in HGMP/CIP with goblet cells but conspicuously on the surface and pits of Barrett’s 
esophagus. MUC5B was seen in both HGMP/CIP and Barrett’s esophagus and rarely in 
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the antral mucosa. The authors concluded that the similarities between HGMP/CIP and 
Barrett’s esophagus but not with normal antral mucosa fit with the hypothesis that both 
lesions may originate from sub-mucosal esophageal mucous glands. Despite this, there 
are differences seen between HGMP/CIP and Barrett’s esophagus. Staining pattern was 
also different between HGMP/CIP and the embryogenic esophagus. The authors of this 
study suggested that HGMP/CIP etiology may be different, congenital in children or 
babies and acquired in adult. 
 
  
 
  
Fig. 5. (a) Cytokeratin (CK) 7 staining of HGMP/CIP showing uptake in the surface 
glandular tissue similar to that seen in Barrett’s esophagus (b). CK20 staining uptakes are 
similar in HGMP/CIP (c) and Barrett’s esophagus (d) 
The HGMP/CIP can also be colonized by Helicobacter pylori and the patches are subjected to 
changes that are seen in the stomach (Akbayir et al., 2004; Alagozlu et al., 2010; Borhan-
Manesh & Franum, 1991 & 1993; Gutierrez et al., 2003; Jacobs et al., 1997; Maconi et al., 2000; 
Poyrazoglu et al., 2009; Tang et al., 2004; Yüksel et al., 2008). Chronic inflammatory changes 
can be seen and progression to atrophy, intestinal metaplasia, dysplasia and malignant 
transformation have been reported (Borhan-Manesh & Franum, 1991). The surrounding 
squamous cell mucosa can also show inflammatory changes similar to those seen in reflux 
esophagitis (Borhan-Manesh & Franum, 1991). 
a) b)
c) d)
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4. Classification 
A clinico-pathologic classification has been proposed by von Rahden et al. (von Rahden et 
al., 2004) which categorized patients with HGMP into five groups (I to V) based on the 
clinical, endoscopic and histological findings (Table 1). This classification also takes into 
account of small patches that may be only visible microscopically. Based on this 
classification, majority of the HGMP/CIP are categorized into types I and II, asymptomatic 
and mildly symptomatic respectively. One study found that the most common lesions are 
types I (73%) and II (27%) lesions.  
 
Category Description Symptoms/findings Frequency 
I Asymptomatic None Common 
II Symptomatic Laryngopharyngeal reflux Common 
III Symptomatic with  
benign complications 
Strictures/webs/fistula/bleeding 
* Polyps 
Uncommon 
IV Intra-epithelial dysplasia None/non-specific Uncommon 
V Malignant transformation Asymptomatic/dysphagia Reported 
Suffix  
a inlet patch (macroscopically visible patch of HGMP/CIP) 
b microscopic foci (only microscopically visible HGMP/CIP) 
Adapted from von. Rahden et al. Heterotopic gastric mucosa of the esophagus: literature-review and 
proposal of a clinicopathologic classification. Am J Gastroenterol. 2004; 99:543-51. 
* Not included in the original classification 
Table 1. Clinico-pathological classification for HGMP/CIP  
5. Clinical manifestations  
The majority of patients found to have HGMP/CIP are asymptomatic and the HGMP/CIP 
are usually detected incidentally while being evaluated with endoscopy for other 
gastrointestinal complaints. The clinical importance of HGMP/CIP remains controversial 
with some authors believe that they are benign and of no clinical relevance. Others have 
shown HGMP/CIP to be clinically important especially for a subset of patients with 
HGMP/CIP. For those who have symptoms attributable to the HGMP/CIP, most are mild 
and are detected only on direct inquiries. For a small proportion of patients, the symptoms 
can be prominent and patients may have many consultations before a diagnosis is made. 
The prevalence of any symptoms, typically those considered extra-esophageal symptoms 
complex of gastroesophageal reflux such as chronic cough, throat irritation or sore throat, 
regurgitation, globus pharyngeus, dysphagia or hoarseness ranges from very low to as high 
as 75% (Chong & Jalihal, 2010; Maconi et al., 2000). 
HGMP/CIP like other ectopic gastric mucosal have been proven to be able to secrete acid in 
sufficient quantity to induce inflammatory changes and acid related symptoms (Baudet et 
al., 2006; Galan et al., 1998; Hamilton et al., 1986; Korkut et al., 2010; Nakalima et al., 1993; 
Yüksel et al., 2008). Acid is the main cause of symptoms in patients with HGMP/CIP. Given 
the proximity of the HGMP/CIP to the laryngopharyngeal area, it is not surprising that  
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Fig. 6. Schematic illustration of cytokeratin (CK) 7 and 20 expression in the normal esophagus, 
Barrett's metaplasia, squamocolumnar junction, and proximal stomach. LATCHFORD A et 
al. Gut 2001; 49:746-747 (Reprinted with permission from GUT BMJJournal) (Latchford et al., 2001). 
even weakly acidic secretion can cause symptoms. Others have proposed that mucin 
secretion can also cause symptoms (Bajbouj et al., 2009). Proximal esophagus dysmotility 
has also been shown to be associated with HGMP/CIP (Korkut et al., 2010). 
Studies that had looked at specific groups of patients, such as those with laryngopharyngeal 
complaints, have found mixed results. The overall prevalence of HGMP/CIP was in the 
similar range compared to studies that had been carried out on patients coming for routine 
endoscopy. One study that had looked specifically at patients with laryngopharyngeal 
reflux found significantly more HGMP/CIP in patients than controls, those without LPR 
symptoms (11.4% vs. 1.6%, p<0.05). These patients also had significantly more laryngeal acid 
reflux documented on pH study (Akbayir N. et al., 2004). Similarly, other studies have 
found more laryngopharyngeal reflux symptoms in patients with HGMP/CIP (Akbayir et 
al, 2004; Baudet et al., 2006; Borhan-Manesh & Franum, 1993; Tang et al., 2004). Another 
study looking at patients who had undergone fundoplications for gastroesophageal reflux 
with laryngeal reflux only found one patient (3.4%) to have HGMP/CIP (Salminen & 
Ovaska, 2009). This patient had a small HGMP/CIP and the authors concluded that 
HGMP/CIP does not have a significant role in laryngopharyngeal reflux in patients with 
gastroesophageal reflux disease. 
Unfortunately, all these studies have not inquired on the same symptoms complex and 
hence make comparison difficult. 
Interestingly, only one study had assessed the size of HGMP/CIP on clinical symptoms and 
did not find significant differences (Chong & Jalihal, 2010). This study categorized 
HGMP/CIP to small/moderate (<15mm) and large (>15mm). Only cough was significantly 
more (50% vs. 8.3%, p=0.022) common in patients with larger patch. Interestingly, patients 
with smaller HGMP/CIP were found to have more globus and regurgitation. Several 
explanations were given for the lack of correlations between size of HGMP/CIP and 
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symptoms and these include; a) missed patches, b) the mucosal types of HGMP/CIP and c) 
the underlying degree of inflammatory changes that can affect acid output. Patients with 
predominant antral mucosal type HGMP/CIP may not have or minimal acid related 
symptoms. Patients with severe inflammatory changes approaching atrophy may have 
reduce acid output, hence minimal symptoms. Interestingly, more patients with HGMP/CIP 
also experienced heartburn compared to those with HGMP/CIP. This patients either had 
non erosive gastroesophageal reflux or symptoms induced by acid secreted by the patch 
flowing down. One study showed that greater acid production was found in those with 
larger HGMP/CIP patch (Baudet et al., 2006). 
6. Diagnosis 
6.1 Endoscopic features  
On endoscopy, HGMP/CIP appears as salmon or velvety colored patch that is clearly 
distinct to the slatey white esophageal squamous cell mucosa (Figure 7). A majority of 
HGMP/CIP is round or ovoid. Some can be elongated with the maximal dimension in the 
longitudinal direction. Rarely, HGMP/CIP can be so big that they cover almost or the entire 
circumference of the esophagus. Smaller patches tend to be round or oval, are usually 
elevated or flat with smooth texture and white edges. Larger patches tend to be depressed 
on maximal insufflations during endoscopic examination and are ovoid or elongated with 
jagged edges and nodular surface textures. Occasionally, inflammatory changes similar to 
those observed in reflux esophagitis can be seen at the edges. Most are single patch and 
 
Authors [Ref] Symptoms Prevalence 
Jacob et al  
[1997] 
Symptoms inquired 
Pharyngeal discomfort, 
Globus, burning sensation in throat, 
odynophagia & 
dysphagia to liquid/solid 
Overall, 9.1% (p=ns) 
Maconi et al  
[2000] 
 
Symptoms 
Dysphagia, throat discomfort and 
heartburn 
Overall, 5.5% (p=ns) 
Overall, 22.2% 
(milder symptoms included) 
Akbayir et al  
[2004] 
Upper esophageal and 
laryngopharyngeal symptoms 
Individual symptoms not defined 
Overall, 45% vs. 21.5% (p=0.07) 
Baudet et al  
[2006] 
Dysphagia 21 vs. 4.0, p<0.001 
Poyrazoglu et al  
[2007] 
Symptoms (not defined) Dysphagia Overall not defined 39.4% vs. 
0% (p<0.05) 
Chong & Jalihal  
[2010] 
Symptoms Chronic cough  
Sore throat/hoarseness  
Globus  
Regurgitation  
Heartburn 
Overall, 73.1% (p<0.05)  
29.2 vs. 10.6% (p<0.01)  
54.2 vs. 11.7% (p<0.01)  
23.1 vs. 7.1% (p<0.01)  
42.3 vs. 13.1% (p<0.01)  
50.0 vs. 22.5% (p<0.01) 
Table 2. Prevalence of symptoms reported to be associated with HGMP/CIP 
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in patients with multiple patches, they tend to be found in close proximity, above or below 
forming columns or on the opposite side (kissing patches). It is uncertain whether the size of 
HGMP/CIP may change with time. One study reported that the size of a HGMP/CIP 
decreased during subsequent endoscopy whilst on acid suppression treatment (Chong & 
Jalihal, 2006). Healing of surrounding inflammation may account for this observation. 
Associated findings include elevated whitish nodules that do not have the characteristic 
salmon colored mucosa. In elderly patients, venous bled or hematoma can also be found. To 
date, the profiles of HGMP/CIP have not been properly studied. Interestingly, HGM can 
also be found in other parts of the esophagus, mid esophagus and above the gastro-
esophageal junction (Borhan-Manesh & Franum, 1991; Katsanos et al., 2010) (Figure 7e).  
It is likely that the overall acid production from the HGMP/CIP is less than that seen in 
gastroesophageal reflux disease affecting the gastroesophageal junction. Acid related 
injuries can be seen in the patch and the surrounding esophageal squamous mucosa. 
Inflammatory macroscopic changes visible during endoscopy or microscopic changes only 
visible on histological examinations resembling those seen in reflux esophagitis have been 
described. 
7. Modalities for detection of HGMP 
7.1 High definition endoscopy  
Use of high definition endoscopy will improve the clarity and definition and can 
differentiate HGMP/CIP from the squamous mucosa. 
7.2 Narrow band imaging  
Narrow band imaging (NBI) which utilizes different light wavelengths has been reported to 
improve the detection rate of HGMP/CIP (Hori et al., 2010; Ohara, 2010). NBI allows better 
visualization of the more superficial features of mucosa. In NBI, the HGMP/CIP appears a 
grayish pink patch surrounded by greenish hued squamous cell mucosa. Occasionally area 
where the thickness of squamous cell layer is less, it can also give the similar appearance but 
in this case, mucosal vessels, greenish in appearance, can still be seen coursing through the 
area. In HGMP/CIP, vessels are not seen. 
7.3 Chromoendoscopy  
HGMP/CIP can also be visualized with chromoendoscopy. Both Lugol’s solution and 
methylene blue can be used to identify HGMP/CIP. Lugol’s solution is iodine based and has 
affinity that has affinity for glycogen in non-keratinized squamous cell epithelium of the 
esophagus. HGMP/CIP will not stain and appear lighter shade compared to the 
surrounding esophagus. Methylene blue will stain HGMP/CIP blue in colour. However, 
this procedure requires the spraying of dye and to do this in the proximal esophagus may 
induce cough reflex causing discomfort to the patient (Dib & Ortiz, 2009). 
7.4 Wired guided examination 
Use of wire guided examination has also been reported to improve the yield. The endoscope 
is withdrawn into the mid-esophagus and a guide wire is threaded through into the 
esophagus. The endoscope is then slowly withdrawn while examining the proximal 
esophagus and crico-pharyngeal area (Bhasin et al., 2006).   
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Fig. 7. Endoscopic images showing different HGMPs; a) a large depressed patch with coarse 
surface texture with another patch located on the opposite wall, b) two small patch with 
smooth surface texture, one elevated and the other flat, c) a large slightly depressed patch 
with coarse surface texture on the right lateral wall, d) two round elevated patch with white 
edges and smooth surface and associated venous bled, and e) a small flat round patch with 
smooth surface texture located above the gastroesophageal junction. All the patches shown 
stained positive for CK7 and CK20 with characteristics pattern 
a) b)
c) d)
e)
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7.5 Radio-nuclear imaging 
Radio nuclear scan has been widely used for the detection of ectopic gastric mucosa especially 
in cases suspected to have Meckel’s diverticulum (Kiratli et al., 2009). Technetium-99m 
pertechnetate scintigraphy can accurately localize the location of HGMP. The role and use of 
nuclear imaging in detecting HGMP/CIP remains unknown. One study reported its use in 
five patients with patches of gastric fundal type columnar epithelium in the proximal 
esophagus at the level of the upper esophageal sphincter diagnosed by upper endoscopy 
(Chen et al., 1989). In all instances, the patches contained both chief cells and mucus-secreting 
cells. Two cases of HGMP/CIP were demonstrated by TcO4-. Unfortunately, TcO4- 
accumulation in the thyroid glands of three patients caused overlapping activity between 
the thyroid gland and HGMP/CIP. It was concluded that TcO4- scintigraphy is only suitable 
for patients who have had a total thyroidectomy or are on suppressive thyroid therapy. 
 
 
Fig. 8. Narrow band imaging showing an ectopic gastric mucosal patch as salmon coloured 
patch with greenish background 
7.6 Contrast fluoroscopy/Barium swallows 
One study showed that careful fluoroscopy study can detect subtle abnormalities that may 
be due to HGMP/CIP (Takeji et al., 1995). This study detected 27 cases of HGMP/CIP 
confirmed on endoscopy and biopsy in 1,142 patients undergoing annual health check. The 
most common radiographic finding was a pair of small indentations on the wall of the 
esophagus (n=18). Other findings included a rim-like shadow (three patches), a pair of large 
indentations with a shallowly depression (two patches), one indentation (five patches), a 
small flat elevation (one patch), a serrated irregular outline (five radiologic lesions consisted 
of 11 patches), other various irregular outlines (two patches), and a polypoid area (one 
patch). One study using barium contrast swallow showed features similar to those 
described for esophageal webs and suggested that in fact, esophageal webs maybe due to 
HGMP/CIP (Ainley, 2011). This study clearly showed that HGMP/CIP produced the same 
imaging features of esophageal web on barium swallow. Chronic acid injuries lead to 
inflammations and subsequent healing results in a web or stricture formation. This has been 
referred to as type AA ring in contrast to the A (muscular ring) and B (Schatzki ring) rings in 
the distal esophagus. 
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7.7 Others 
Use of proximal pH monitoring can also provide clue to the presence of HGMP/CIP. 
Presence of acid pH detected in the proximal esophagus without acidic pH detected in the 
distal esophagus suggests the presence of HGMP/CIP. However, both gastroesophageal 
reflux and proximal acid reflux secondary to HGMP/CIP may co exist. Endoscopic imaging 
will still be required to confirm the presence of HGMP/CIP. Use of confocal microendoscopy 
for the diagnosis has also been reported. 
8. Complications 
Complications of HGMP/CIP are those cases classified under the clinico-pathological 
classification as types III to V (von Rahden et al., 2004). To date, there have been around 
thirty cases of cervical esophagus adenocarcinoma (type V) reported (Abe et al., 2004 ; 
Alaani et al., 2007 ; Alrawi et al., 2005 ; Balon et al., 2003; Berkelhammer et al., 1997; Carrie, 
1950; Chatelain et al., 2002; Christensen & Sternberg, 1987; Clemente, 1974; Danoff et al., 
1978; Davis et al., 1969; Goëau-Brissonnière et al., 1985; Haruki et al., 2008 ; Hirayama et al., 
2003; Ishii et al., 1991; Kammori et al., 1996; Kamiya et al., 1983; Klaase et al., 2001; Lauwers 
et al., 1998 ; Morson & Belcher, 1952; Noguchi et al., 2001 ; Pai et al., 1997; Pech et al., 2001; 
Raphael et al., 1966; Sakamoto et al., 1970; Schmidt et al., 1985; Sperling & Grendell, 1995; 
Takagi et al., 1995;  von Rahden et al., 2004 & 2005; Yoshida et al., 1986; Yoshida et al., 2010) 
in the literature. Other non-malignant complications (types III and IV) have been reported in 
both children and adults and are shown in Table 1 (Sauvé et al., 2001; Mion et al., 1996; 
Steadman et al., 1988; Yarborough et al., 1993; Bosher & Taylor, 1951; Powell & Luck, 1988; 
Karnak et al., 1999; Buse et al., 1993; Waring & Wo, 1997; Weaver, 1979; Bataller et al., 1995; 
Kohler et al., 1988; Garcia et al., 2002; Daher et al., 2010; Sánchez-Pernaute et al., 1999; 
Righini et al., 2007 ; Chatelain et al., 1998; Oguma et al., 2005 ; Rana et al., 2006 ; Schulewitz 
et al., 2007). Proximal esophageal web or stricture associated with Plummer-Vinson or 
Paterson-Kelly-Brown syndrome associated with sideroblastic anemia is now believed to 
complication of HGMP/CIP (Ainsley, 2011). Table 3 shows the listed of reported 
complications associated with HGMP/CIP.  
8.1 Other possible associated with HGMP/CIP 
Other conditions reported to be associated with laryngopharyngeal reflux include chronic 
obstructive airway disease exacerbations, obstructive sleep apnea and laryngopharyngeal 
neoplasms (Eryuksel et al., 2009; Wise et al., 2006; Copper et al., 2000). Indirectly, there may 
be association with HGMP/CIP (Basseri et al., 2009; Satoh et al., 2007). 
9. Treatment/management 
The management of patients with HGMP/CIP depends on the presence of symptoms or 
complications following the clinico-pathological classification proposed by von-Rahden. For 
the majority of patients, HGMP/CIP are detected incidentally (type I) and as such do not 
require any treatment, follow up or surveillance. For patients with acid related symptoms, 
treatment with acid suppression with or without pro-kinetic and antacid will suffice. For 
majority, a short course of treatment will be adequate. However, for a proportion, 
prolonged acid suppression similar to patients with significant gastro-esophageal reflux 
disorders may be required.  
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Other reported modalities for treating symptomatic non neoplastic HGMP/CIP include 
argon plasma coagulation and endoscopic mucosal resection. However, these modalities 
have only been reported in small series.  
For those cases with complicated HGMP/CIP (type III), apart from acid suppressions, other 
modalities such as dilatation for stricture and even surgery may be required.  
Type IV cases will require close follow up treatment may include argon plasma coagulation 
(Sauvé et al., 2001; Klaase et al., 2001), endoscopic mucosal resection (EMR) and endoscopic 
sub-mucosal dissection (ESD). For those with type V HGMP/CIP, treatment will depend on 
the stages of disease. Early adenocarcinoma can be treated with EMR or ESD. These can be 
resected after the creation of a polyp by rubber band ligation or with cap assisted EMR. For 
other cases, surgical resections are indicated. 
It remains unknown whether patients detected to have HGMP/CIP requires to be followed 
up for future complications or progressions to types III to V. Patients found on biopsy to 
have dysplastic HGMP/CIP mucosa will require surveillance. It is unknown what time 
interval is recommended. Given that HGMP/CIP is gastric mucosa, following the 
recommendations for stomach will probably be adequate. 
10. Controversies 
Currently, there are several controversies regarding HGMP/CIP. First, there is still dispute 
with regard to the origin of HGMP/CIP. However, it is widely believed to be congenital 
origin as result of remnant of columnar epithelium due to failure of complete squamization 
of the esophagus. There are several factors that favor the congenital origin hypothesis. The 
embryogenesis of esophagus can explain the profiles of HGMP/CIP; proximal location 
correlating with the last part of the esophagus, the proximal esophagus to transform to 
keratinized mucosa. Babies and children do not have sufficient duration of acid exposure to 
induce changes suggested by the acquired theory. Finally, although the staining pattern 
based on CK7 and CK20 are similar, staining with MUC protein shows differences between 
HGMP/CIP and Barrett’s (Lauwers et al., 2005). 
An earlier study had also shown that the HGMP/CIP had cellular component different from 
Barrett’s esophagus, suggesting embryogenic in origin (Fuerle et al., 1990). 
The proposed theory on acquired origin was based on similarities between histological 
findings of HGMP/CIP and Barrett’s esophagus. Mucin protein (MUC) and CK7 and CK20 
similarities suggested similar origin. Other study based on MUC also suggested HGMP/CIP 
being acquired in origin. In the future, other staining methods may be identified and may 
show clear differences between HGMP/CIP and Barrett’s esophagus. Weak evidence come 
from higher incidence of Barrett’s esophagus in patients found to have HGMP/CIP. 
However, the overall reported incidence rates are still too low to lend strong support for this 
theory.  
The latest theory proposed was based on findings of glandular cystic retentions secondary 
in the proximal esophagus. The evidence to support this theory are lacking given the very 
few reports of glandular retention cysts encountered in the clinical practice and reported in 
the literature. Furthermore, the absence of lesions found in the other part of esophagus 
makes the second and the third proposed theories less likely. Interestingly, it has also been 
proposed that the origin may be different, congenital in baby or children and acquired in 
adult (Lauwers et al., 2005). 
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Second, the actual incidence of HGMP/CIP is not exactly known. Earlier endoscopic studies 
have reported rates ranging from 0.35 to 10.0% and a latest study that had used NBI 
reported a rate of 13.8% (Ohara, 2010). An autopsy studies have reported rate as high as 
70%. However, autopsy studies on paediatric population in the mid-twentieth century had 
only reported rates of less than 10%. With the advent of newer imaging modalities that 
provide superior endoscopic images, this will provide more accurate incidence. The true 
incidence rates are likely to be close to the rates reported by NBI studies given the clear 
distinction of HGMP/CIP observed with NBI. In future studies, it is very important that the 
endoscopists are aware and to look for this lesions. Several studies have already reported 
that the pick up rates were higher when endoscopist were aware of the entity (Maconi et al., 
2000; Azar et al., 2007).  
The third controversy relates the clinical significance of HGMP/CIP in clinical practice. 
While many have found low prevalence of symptoms in associated with HGMP/CIP, it is 
no doubt that HGMP/CIP have clinical significance given the reported complications that 
include malignant transformations.  
Other controversies include suggested association with extra-esophageal cancers in the aero-
digestive tract. Incidence of laryngeal carcinoma has been shown to be higher in patients 
with laryngopharyngeal reflux disorder (Copper MP et al., 2000).   
11. Future areas 
HGMP/CIP remains a mysterious entity that have not been well studied compared to other 
esophageal disorders. Encouragingly, in the last decade, the number of publications on 
HGMP/CIP has been increasing. However most of these studies have only looked at the 
clinical and histological profiles without further addressing newer areas that can help to 
address the controversies that still surround HGMP/CIP. Future areas of interest include 
addressing the controversies that still surround HGMP/CIP. Other areas of interest are 
highlighted in Table 4. 
12. Overview 
Endoscopy is important part of our armamentarium for the evaluation of suspected 
gastrointestinal pathologies. Significant pathologies commonly encountered in the upper 
gastrointestinal tract include gastro-esophageal reflux related disorders (esophagitis, ulcers 
and strictures), varices, esophageal tumor, gastric ulcers, gastric tumor and duodenal ulcers. 
Most clinicians and endoscopists are aware of these pathologies. The proximal esophagus is 
frequently neglected during endoscopy with little time spent to examine this area. 
Pathologies found in or around the proximal esophagus include HGMP/CIP, Zenker’s 
diverticulum, esophageal web, downhill varices and venous blebs or hematoma.  
HGMP/CIP is an interesting clinical entity that still hold many mysteries and is still 
relatively under-recognized and unknown to many clinicians, even those who manage 
patients with laryngopharyngeal reflux disorders. It was first reported by Schmidt in 1805 
(Schidmt, 1805). There are still very few publications compared to other esophageal disorders 
and only in the last decade the number of publications on this entity has increased, albeit 
slightly.   
The proximal location of the HGMP/CIP contributes to the low detection as this area is 
difficult to examine. Endoscopists need to be aware and look for this condition. Studies have 
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shown higher pick up rate when the lesions are being looked for. HGMP/CIP can also be 
found in the other part of the esophagus. On endoscopy, HGMP/CIP appears as a salmon-
colored or velvety patch on white light endoscopy that is distinct from the esophageal 
squamous mucosa. HGMP/CIP may appear different color on other imaging techniques. 
Use of confocal endoscopy has been reported for the diagnosis of HGMP/CIP (López-Cerón 
Pinilla M et al., 2011). Majority of HGMP/CIP are solitary but can be multiple and the sizes 
can range from very small to very large. In patients with multiple patches, they are usually 
small and are located in close proximity of each other. They are typically found on the right 
or left lateral esophageal wall but can also be circumferential. They are usually oval, ovoid 
or round but can be elongated in shape.  
 
Current controversies 
Origin of HGMP/CIP- Congenital/Acquired 
Clinical significance 
Exact incidence 
Others 
Best method of detection 
 Magnification endoscopy 
 Narrow band imaging 
 Chromoendoscopy 
 Others 
Role of measuring acid output and clinical correlation with symptoms 
Method of measuring the surface area- Exact size of HGMP/CIP 
Role in clinical symptoms 
 Acid 
 Non acidic secretion 
Surrogate markers of histological activities of HGMP/CIP 
Treatment modalities for the various types of HGMP/CIP 
Role of Helicobacter pylori in histological progression and  
 malignant transformation 
Table 4. Future areas to address on HGMP/CIP 
HGMP/CIP is reported to cause laryngopharyngeal reflux or extra-esophageal symptoms of 
gastro-esophageal reflux disorder. The reported frequency of laryngopharyngeal reflux 
symptoms ranged from very low to as high as 75% in patients with HGMP/CIP (Chong & 
Jalihal, 2010). Fortunately, most laryngopharyngeal reflux symptoms are mild. However, 
complications such as ulcerations, strictures, perforation and malignant transformation have 
been reported (von Rahden et al., 2004). Associations with higher frequency of 
laryngopharyngeal malignancies in patients with laryngopharyngeal reflux have also been 
reported.  
The current clinico-pathological classification proposed by von-Rahden et al. provides a 
useful classification of the various manifestations of HGMP/CIP (von Rahden et al., 2004). It 
also guides clinical management which largely depends on the presence and severity of 
symptoms. Management is mainly with pharmacotherapy and instrumentations (endoscopic) 
and surgery may be required for complicated cases. Ablative therapies with argon plasma 
coagulation have been reported to provide symptoms relieve or cure in those with globus 
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pharyngeus (Bajbouj M et al., 2009). Use of argon plasma has also been reported to be 
effective for dysplasia and early carcinoma. EMR or ESD have been reported to be successful 
for curative treatment of pT1 lesions whereas surgery is required for more advanced lesions.  
Controversies remain regarding the origin, clinical significance and the true incidence of 
HGMP/CIP. From current available evidence, it seems more likely that HGMP/CIP is 
congenital in origin. Despite the overall benign nature of the condition with most being 
categorized as type I (asymptomatic), serious complications including malignant 
transformation have been reported. It remains unknown how malignant transformation 
occur; whether it follows the established sequence of atrophy, metaplasia, dysplasia to 
neoplasia for Barrett’s adenocarcinoma or Helicobacter pylori associated adenocarcinoma 
sequence. 
Interesting future areas include studies to address the controversies mentioned, the role of 
newer imaging techniques to increase the diagnosis and distinguish the underlying 
histological profiles of HGMP/CIP, the role and significance Helicobacter pylori in symptoms 
or histological progression (whether it share similarities with gastric and Helicobacter pylori), 
ways of measuring size of patch and acid output, role of acid or mucin secretion in 
symptoms and possible surrogate markers for assessing histological activities of the 
HGMP/CIP. Biopsies of the HGMP/CIP can be difficult and it is uncertain whether the 
histological activities of HGMP/CIP parallel that of the gastric mucosa within the antrum, 
body or fundus. 
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